Skip to main content

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Integración de datos del mundo real, de salud y de investigación para la mejora de los protocolos clínicos en la enfermedad falciforme y otras anemias raras

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , David Beneitez Pastor, Maria Cristina Díaz de Heredia Rubio, Adoración Blanco Alvarez
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI24/00477
Duration: 01/01/2025 - 31/12/2027

ERDERA: European Rare Disease Research Alliance

IP: M Mar Mañu Pereira
Collaborators: Augusto Cesar Sao Aviles, Patricia González Ruiz, Claire Diot, Miguel Chillon Rodriguez, Simon Schwartz Navarro, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 1252083.33
Reference: ERDERA/EC/HLTH-2023-DISEASE-07-01/2023/MAÑU
Duration: 01/09/2024 - 31/08/2031

ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases)

IP: M Mar Mañu Pereira
Collaborators: Raquel Mosull del Campo, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 1569581.5
Reference: EUROBLOODNET-ERN_EU4H2023
Duration: 01/10/2023 - 30/09/2027

ERN-EuroBloodNet: EUROPEAN REFERENCE NETWORK ON RARE HEMATOLOGICAL DISEASES

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Claire Diot, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 371825
Reference: EUROBLOODNETBR2022_EU4H-ERN2022
Duration: 01/05/2022 - 30/11/2023

Related news

The integration of Patient-Reported Outcome Measures (PROMs) will make it possible to incorporate patients' experiences and quality of life into research on sickle cell disease and other rare anaemias.

The Scientific Coordinator of ERN-EuroBloodNet will lead for one year the group that defines the common strategy of the European Reference Networks to improve care for rare and complex diseases.

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

Related professionals

Aroca Alsina, Montserrat

Aroca Alsina, Montserrat

Research assistant
Clinical Neuroimmunology
Read more
Mont Bonada, Anna

Mont Bonada, Anna

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Herrera Rey, Lara

Herrera Rey, Lara

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Alberich Jordà, Manel

Alberich Jordà, Manel

Research technician
Neuroradiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.